BHC Живые сигналы | Максимизируйте прибыль с Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 апр. 2024 @ 23:00):

Stats
Объем за сегодня	2.07M
Средний объем	2.83M
Рыночная капитализация	3.18B
EPS	$0 ( 2024-02-22 )
Дата следующего отчета о доходах	( $0.740 ) 2024-05-02
Last Dividend	$1.000 ( 2010-11-10 )
Next Dividend	$0 ( N/A )
P/E	-5.38
ATR14	$0.00800 (0.09%)

Insider Trading

Date	Person	Action	Amount	type
2024-03-29	Paulson John	Buy	5 890	Common Shares, No Par Value
2024-03-29	Icahn Brett	Buy	3 122	Common Shares, No Par Value
2024-03-29	Robertson Russel C	Buy	2 945	Common Shares, No Par Value
2024-03-29	Wechsler Amy B	Buy	647	Common Shares, No Par Value
2024-02-29	Barresi John S	Buy	39 126	Common Shares, No Par Value

INSIDER POWER
67.94
Last 100 transactions
Buy: 2 132 507 \| Sell: 336 154

Объем Корреляция

Длинно: -0.11 (neutral)

Кратко: 0.07 (neutral)

Signal:(46.694) Neutral

Bausch Health Companies Корреляция

10 Самые положительные корреляции
YSAC	0.851
PKE	0.81

10 Самые отрицательные корреляции

Вы знали?

Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).

Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.

Bausch Health Companies Корреляция - Валюта/Сырье

0.00
( neutral )

0.16
( neutral )

0.00
( neutral )

0.24
( neutral )

Bausch Health Companies Финансовые показатели

Annual	2023
Выручка:	$8.76B
Валовая прибыль:	$6.20B (70.78 %)
EPS:	$-1.620

FY	2023
Выручка:	$8.76B
Валовая прибыль:	$6.20B (70.78 %)
EPS:	$-1.620

FY	2022
Выручка:	$8.12B
Валовая прибыль:	$5.76B (70.90 %)
EPS:	$-0.590

FY	2021
Выручка:	$8.43B
Валовая прибыль:	$6.04B (71.61 %)
EPS:	$-2.67

Financial Reports:

No articles found.

Bausch Health Companies Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)	$0 (N/A)

Bausch Health Companies Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 6.11 - average (70.51%) | Divividend Growth Potential Score: 2.84 - No dividend growth expected in the near future

Information

First Dividend	$0.500	2005-11-28
Last Dividend	$1.000	2010-11-10
Next Dividend	$0	N/A
Payout Date	2010-12-22
Next Payout Date	N/A
# dividends	22	--
Total Paid Out	$6.43	--
Avg. Dividend % Per Year	0.00%	--
Score	3.06	--
Div. Sustainability Score	6.11
Div.Growth Potential Score	2.84
Div. Directional Score	4.48	--

Next Divdend (Est)
(2024-06-07)

$0 Estimate 0.00 %

Dividend Stability

0.05 Very Bad

Dividend Score

3.06

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
2005	$0.500	3.07%
2006	$0.500	2.01%
2007	$2.00	9.47%
2008	$1.500	11.20%
2009	$0.645	6.68%
2010	$1.280	8.72%
2011	$0	0.00%
2012	$0	0.00%
2013	$0	0.00%
2014	$0	0.00%
2015	$0	0.00%
2016	$0	0.00%
2017	$0	0.00%
2018	$0	0.00%
2019	$0	0.00%
2020	$0	0.00%
2021	$0	0.00%
2022	$0	0.00%
2023	$0	0.00%
2024	$0	0.00%

Dividend Commentary

With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend Knight	2023-06-30	Quarterly	2	5.23%	8.53
VGI	Dividend Royal	2024-02-09	Monthly	13	7.36%	8.50
PHK	Dividend Royal	2023-11-10	Monthly	22	6.88%	8.50
JQC	Dividend Royal	2023-11-14	Monthly	22	6.56%	8.50
PCF	Dividend King	2023-12-18	Monthly	38	7.05%	8.50
PVL	Dividend King	2023-11-15	Monthly	14	9.37%	8.50
NCV	Dividend Royal	2024-02-09	Monthly	22	7.68%	8.50
MTR	Dividend Diamond	2023-10-30	Monthly	39	10.10%	8.50
SBR	Dividend Royal	2023-11-14	Monthly	38	7.74%	8.50
PDI	Dividend Royal	2023-11-10	Monthly	13	7.86%	8.50

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	-0.0190	1.500	-0.379	-0.569	[0 - 0.5]
returnOnAssetsTTM	-0.00607	1.200	-0.202	-0.243	[0 - 0.3]
returnOnEquityTTM	0.171	1.500	9.21	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.301	0.800	8.50	6.80	[1 - 3]
quickRatioTTM	0.685	0.800	-0.679	-0.543	[0.8 - 2.5]
cashRatioTTM	0.220	1.500	9.89	10.00	[0.2 - 2]
debtRatioTTM	0.819	-1.500	10.00	-10.00	[0 - 0.6]
interestCoverageTTM	-0.725	1.000	-1.380	-1.380	[3 - 30]
operatingCashFlowPerShareTTM	3.00	2.00	9.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	2.23	2.00	8.89	10.00	[0 - 20]
debtEquityRatioTTM	-21.91	-1.500	-10.00	10.00	[0 - 2.5]
grossProfitMarginTTM	0.995	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.110	1.000	9.80	9.80	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.0489	1.000	-0.839	-0.839	[0.2 - 2]
assetTurnoverTTM	0.320	0.800	-1.199	-0.959	[0.5 - 2]
Total Score				6.11

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	-19.16	1.000	-2.04	0	[1 - 100]
returnOnEquityTTM	0.171	2.50	9.49	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	2.23	2.00	9.26	10.00	[0 - 30]
dividendYielPercentageTTM	0	1.500	0	0	[0 - 0.4]
operatingCashFlowPerShareTTM	3.00	2.00	9.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.390	1.500	-5.93	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.125	1.000	9.37	0	[0.1 - 0.5]
Total Score				2.84

Bausch Health Companies

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

Обновления в реальном времени для Bausch Health Companies [BHC]

Upcoming Earnings Alert

Bausch Health Companies Dividend Information - Ex Dividend Knight

Dividend Commentary

Top 10 dividend Companies for NYSE

Dividend Sustainability Score (DSS)

Dividend Growth Score (DGS)